Invention Grant
- Patent Title: Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
-
Application No.: US14904817Application Date: 2014-07-15
-
Publication No.: US09717712B2Publication Date: 2017-08-01
- Inventor: Alan Xiangdong Wang , Omar D. Lopez , Yong Tu , Makonen Belema
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo
- International Application: PCT/US2014/046685 WO 20140715
- International Announcement: WO2015/026454 WO 20150226
- Main IPC: A61K31/415
- IPC: A61K31/415 ; A61K31/4184 ; A61K31/4178 ; A61K38/21 ; A61K31/7056
Abstract:
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
Public/Granted literature
Information query
